-
Regeneron, Bayer commence phase-3 trial for diabetic macular edema treatment
TARRYTOWN, N.Y. and BERLIN — Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.
The drug makers said that it would evaluate the efficacy of VEGF Trap-Eye (aflibercept ophthalmic solution) in the treatment of diabetic macular edema, a prevalent cause of vision loss among diabetes patients, after promising results from its previous clinical trial.
-
New app offers diabetics meal planning tips
WALTHAM, Mass. — Quantia has partnered with dietitian and diabetes educator Hope Warshaw to develop EatSmart, a mobile diabetes application.
EatSmart, currently a free download available for the iPhone, Android, smartphones, tablets and the Web, is an app that provides those affected by or at risk for Type 2 diabetes with simple meal planning tips and tricks.